康聯生醫科技股份有限公司 Approved
最後更新時間 2025/07/10 , 10:05 PM
最後更新時間 2025/07/10 , 10:05 PM
負責人
Huang,Ying-Shi
統一編號
24291669
成立日期
2009/01/10
資本額
NT$1,000,000,000
實收資本額
NT$453,501,330
股票代號
6665
電話
02-5569-6199
地址
5F, No. 54, Sec. 1, Zhongsiao E. Rd., Zhongzheng Dist., Taipei City, 100, Taiwan
董監事
姓名 職稱 持有股份 代表法人
Huang,Ying-Shi Chairman 37.97% HONG YANG ENTREPRENEURSHIP INVESTMENT CO., LTD.
Vacancy Director 37.97% HONG YANG ENTREPRENEURSHIP INVESTMENT CO., LTD.
Zou,Ya-Yu Director 37.97% HONG YANG ENTREPRENEURSHIP INVESTMENT CO., LTD.
Hong,Rui-Tai Director 37.97% HONG YANG ENTREPRENEURSHIP INVESTMENT CO., LTD.
Li,Shu-Xing Independent Director 0.00%
Cai,Gan-Ren Independent Director 0.00%
Yan,Zhi-Zhan Independent Director 0.00%
營業項目
  • Management Consultancy Activities(702099)
  • Medical Test and Examination Activities(869100)
  • Retail Sale of Other Food, Beverages and Tobacco in Specialized Stores(472999)
  • 公司歷程
  • Change Person in Charge to Huang,Ying-Shi
    2023/07/10
  • Change Person in Charge to Lin,Qun-Lun
    2022/04/06
  • Change Capital to 1,000,000,000
    2019/07/03
  • Change Capital to 470,000,000
    2015/06/03
  • Change Capital to 287,903,000
    2014/10/27
  • Change Person in Charge to Wu,Liang-Xiang
    2013/01/24
  • 員工人數
    財務報表
    項目 2024 2023 2022
    Operating income 597,146 1,255,818 1,545,319
    Operating cost 489,738 1,010,371 1,232,639
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 107,408 245,447 312,680
    Unrealized profit (loss) on sales of goods - - -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net 107,408 245,447 312,680
    Operating expenses 115,779 242,497 251,819
    Other gain (loss), net - - -
    Operating profit (loss) -8,371 2,950 60,861
    Non-operating income and expenses 10,668 13,425 9,421
    Net profit (loss) before tax 2,297 16,375 70,282
    Income tax expense (benefits) 2,084 14,018 44,840
    Net profit (loss) of ongoing business for the current period 213 2,357 25,442
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period 213 2,357 25,442
    Other comprehensive profit (loss), net 11,062 -7,541 16,353
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period 11,275 -5,184 41,795
    Net profit (loss) attributable to owners of parent company 213 2,357 25,442
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests - - -
    Comprehensive profit (loss) attributable to owners of parent company 11,275 -5,184 41,795
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests - - -
    Basic earnings per share (yuan) 0 0 0
    項目 2024 2023 2022
    Net cash inflow (outflow) from operating activities -29,407 62,840 166,868
    Net cash inflows (outflows) from investing activities -182,321 -147,065 -59,251
    Net cash inflow (outflow) from financing activities -77,705 -26,381 -194,803
    Effect of Exchange Rate Changes on Cash and Cash Equivalents 8,707 -7,537 15,472
    Increase (decrease) in cash and cash equivalents in the current period -280,726 -118,143 -71,714
    Beginning balance of cash and cash equivalents 649,668 767,811 839,525
    Ending balance of cash and cash equivalents 368,942 649,668 767,811
    項目 2024 2023 2022
    Current asset 1,081,043 1,184,724 1,345,154
    Non-current asset 332,600 354,218 319,133
    Total asset 1,413,643 1,538,942 1,664,287
    Current liability 404,372 531,790 625,498
    Non-current liability 83,896 90,696 96,470
    Total liability 488,268 622,486 721,968
    share capital 453,501 453,501 459,541
    Equity - secruity token - - -
    capital reserve 49,986 49,986 50,457
    retained earning 425,275 427,418 483,244
    Other equity -3,387 -14,449 -6,908
    Treasury stock 0 0 -44,015
    Total equity attributable to owners of parent company 925,375 916,456 942,319
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests - - -
    Total Equity 925,375 916,456 942,319
    Share capital awaiting retirement (unit: share) 0 0 0
    Issued shares of advance equity (unit: shares) 0 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 0 0 604,000
    Net asset value per share 20 20 20
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
  • Healthconn
  • 康聯
  • 御能
  • 康聯預防醫學 HEALTHCONN
  • H 圖騰
  • 專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
    勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。